on PREDILIFE (EPA:ALPRE)
Predilife publishes its 2024 half-yearly financial report
On October 30, 2024, Predilife announced the availability of its half-yearly financial report for the current year. This publication has been filed with the Autorité des Marchés Financiers. The details of the report are available on the company's website, under the section dedicated to regulated information.
Predilife, listed on Euronext Growth, specializes in pathological risk prediction solutions. The company relies on artificial intelligence technologies applied to medical and genetic data, in order to personalize patient monitoring and detect diseases early.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all PREDILIFE news